Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.

Transaction summary

Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($92.55).

Key questions

• How does this merchantability comparison to Roger E. Susi's established transaction pattern?
  The 7,500-share merchantability is accordant with the caller cadence of regular 7,500 to 10,000-share transactions, reflecting a systematic disposition strategy arsenic indicated by 63 anterior merchantability events implicit the past 3 years.

• What is the root and operation of the shares sold successful this filing?
  All shares were held indirectly done designated spot entities, with the reporting idiosyncratic holding zero nonstop shares some earlier and aft the transaction, underscoring a reliance connected indirect ownership for liquidity activity.

• What percent of Susi's remaining presumption was affected?
  The transaction impacted conscionable 0.17% of full and indirect holdings, leaving the bulk of the indirect presumption — implicit 4.4 cardinal shares — intact arsenic of April 21, 2026.

• How does existent marketplace show contextualize this sale?
  As of the transaction date, Iradimed shares had appreciated 68.79% implicit the anterior year.

Company overview

* 1-year terms alteration calculated utilizing April 21st, 2026 arsenic the notation date.

Company snapshot

• Iradimed Corporation develops and markets MRI-compatible aesculapian devices, including intravenous infusion pump systems and diligent captious signs monitoring systems, on with related accessories and disposables.

• It generates gross chiefly done nonstop income of proprietary aesculapian devices and consumables, supported by a tract income squad and autarkic distributors.

• The institution serves hospitals, acute attraction facilities, and outpatient imaging centers successful the United States and internationally.

Iradimed Corporation is simply a specialized aesculapian instrumentality shaper focused connected MRI-compatible equipment, enabling harmless diligent attraction successful MRI environments. The company's strategy centers connected proprietary exertion and a nonstop income attack to thrust adoption successful captious healthcare settings.

Its competitory borderline lies successful addressing the unsocial information requirements of MRI procedures, supporting some operational ratio and diligent outcomes.